Home
Live Updates
New Data Demonstrates KarXTs Positive Long-Term Metabolic Profile : comparemela.com
New Data Demonstrates KarXT's Positive Long-Term Metabolic Profile
Learn more about the latest data on KarXT, which is posed to be the first new pharmacological treatment for schizophrenia.
Related Keywords
Italy ,
Goodideas Adobestock ,
Roland Chen ,
Bristol Myers Squibb ,
Drug Administration ,
Schizophrenia International Research Society ,
Annual Congress ,
Segal Trials ,
Bristol Myers ,
Myers Squibb ,
Schizophrenia International Research ,
comparemela.com © 2020. All Rights Reserved.